ArticleApplied biochemistry and biotechnology2025
Protein Nanocages as Building Blocks for Conjugated Supramolecular Materials Displaying Multitasking Properties.
Article in Applied biochemistry and biotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Protein nanocages are a group of compartments naturally enclosing nucleic acids or proteins for biological purposes. Such materials have also inspired the design of novel proteins displaying self-assembling properties. The most studied protein nanocages are viral capsids and their derivative virus-like particles (VLPs), which consist of any or all of the structural proteins of the virion but lack nucleic acids and are therefore non-infectious. VLPs can be used as vaccine antigens or decorated with heterologous antigens to develop new vaccine materials. External surfaces of VLPs can also be decorated with chemical substances to impart new properties, like fluorescence tags or binding to cellular receptors. In addition, the internal space of VLPs can be used to encapsulate therapeutic materials that can be carried to specific cells or tissues. Although VLPs are naturally polyvalent and can display more than one decorating element, it is possible to expand the repertoire of decorating species by specifically conjugating different VLPs, which can be decorated with different functional elements. Here, VLPs of parvovirus B19 displaying different functional proteins were linked through the SpyTag-SpyCatcher biorthogonal conjugation technology. Characterizing the resulting species demonstrated the bioconjugation and the presence of the individual properties of each component. This proof-of-concept research implies that novel multitasking biomaterials can be constructed from protein nanocages and that the application landscape is vast and highly expandable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.